The idea of a prestigious research company preparing and publishing a report on a Pinksheet stock is a little perplexing. First of all most brokerage houses will not let their broker recommend pink sheet stocks (or any stock usually below $4 or %5 per share). Secondly few institutions buy pinksheet stocks. So one has to wonder why this company would spend the time, money, and effort to produce a report that could only be acted on by the penny stock buying world.
